Topics

Rebiotix Inc. Company Profile

09:02 EDT 18th July 2019 | BioPortfolio

Rebiotix Inc, which is part of the Ferring Pharmaceuticals Group, is a late-stage clinical microbiome company focused on harnessing the power of the human microbiome to revolutionize the treatment of debilitating diseases. Rebiotix possesses a deep and diverse clinical pipeline, with its lead drug candidate, RBX2660, in Phase 3 clinical development for the prevention of recurrent Clostridium difficile (C. diff) infection. RBX2660 has been granted Fast Track status, Orphan Drug and Breakthrough Therapy designation from the FDA for its potential to prevent recurrent C. diff infection. Rebiotix’s clinical pipeline also features RBX7455, a lyophilized non-frozen, oral capsule formulation, which is currently the subject of an investigator-sponsored Phase 1 trial for the prevention of recurrent C. diff infection. In addition, Rebiotix is targeting several other disease states with drug products built on its pioneering Microbiota Restoration Therapy™ platform. The MRT platform is a standardized, stabilized drug technology that is designed to rehabilitate the human microbiome by delivering a broad consortium of live microbes into a patient’s intestinal tract via a ready-to-use and easy-to-administer format. For more information on Rebiotix and its pipeline of human microbiome-directed therapies, visit www.rebiotix.com.


News Articles [7 Associated News Articles listed on BioPortfolio]

Sorting through the #microbiome is a messy task, but someone's got to do it. Careful parsing of #probiotics may pave the way for FDA approval. Companies like @Rebiotix and @SeresTX are going for it: https://www.nature.com/articles/s41591-019-0351-4 …

Sorting through the #microbiome is a messy task, but someone's got to do it. Careful parsing of #probiotics may pave the way for FDA approval. Companies like @Rebiotix and @SeresTX are going for i...

Microbiome Health Index™ Platform to be Presented at Gut Microbiota for Health Summit 2019

Rebiotix’s prototype index is under development to measure impact of microbiota-based therapeutics on Clostridium difficile infection patient microbiomes ...

Ferring Favorite To Get First Approval For Microbiota-Based Therapy

If all goes well, 2020 could see the Swiss firm's Rebiotix subsidiary get a green light from the FDA for...    

Microbiota Restoration Takes the Podium at DDW 2019: Investigational Microbiota-Based Therapies for Recurrent C. diff Highlighted

Phase 2 liquid suspension and Phase 1 lyophilized, non-frozen, oral capsules containing live microbes were studied in clinical trials; results are an important step i...

Ferring, Rebiotix and Karolinska Institutet Extend Collaboration to Research Next Generation of Microbiome Treatments

Collaboration brings together expertise from Ferring, Rebiotix and Karolinska Institutet to unlock the potential of the human microbiome The collaboratio...

Ferring International Center SA Strategic SWOT Analysis Review [Report Updated: 31012019] Prices from USD $125

Ferring International Center SA Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains ...

Rebiotix Leaders to Discuss Microbiome Product Development Challenges and Regulation at Microbiome Movement – Drug Development Summit 2019

Rebiotix, Inc, a Ferring Pharmaceuticals company, announced today that two members of their senior leadership team, Dr. Ken Blount, Chief Scientific Officer and Dr. Edward Burd, Head of Regulatory Af...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Rebiotix Inc.

Rebiotix Inc, which is part of the Ferring Pharmaceuticals Group, is a late-stage clinical microbiome company focused on harnessing the power of the human microbiome to revolution...

Rebiotix, Inc

More Information about "Rebiotix Inc." on BioPortfolio

We have published hundreds of Rebiotix Inc. news stories on BioPortfolio along with dozens of Rebiotix Inc. Clinical Trials and PubMed Articles about Rebiotix Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Rebiotix Inc. Companies in our database. You can also find out about relevant Rebiotix Inc. Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record